Esperion治療ESPR

那斯達克 · USD
2.92
+0.03
(+1.04%)
盤中 01/22 02:14 (UTC+8)
01/22 02:14 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.26
  • 0.34
  • 0.32
  • 1.38
  • 0.74
  • 0.52
  • 0.69
  • 0.65
  • 0.82
  • 0.87
icon
  • 5.99
  • 31.73
  • -5.06
  • 327.09
  • -46.39
  • -30.07
  • 33.86
  • -5.96
  • 26.76
  • 5.98
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
營業收入淨額
87,309
82,385
64,995
69,113
51,632
73,834
137,735
32,250
33,969
25,786
營業成本
41,28928,54331,53825,63117,28615,60910,07511,45213,3776,786
營業毛利
46,020
53,842
33,457
43,482
34,346
58,225
127,660
20,798
20,592
19,000
營業費用
55,97946,747-----63,16548,12556,058
研發費用
14,1317,23812,55710,97710,39711,46113,40317,74214,88522,099
推銷及管理費用
41,84839,50942,99636,92539,97544,18541,98845,42333,24033,959
非經常性項目費用
----------
其他營業費用
----------
營業利益
-9,959
7,095
-22,096
-4,420
-16,026
2,579
72,269
-42,367
-27,533
-37,058
其他收入及費用
6776661,072-4761,584-50,7812,7771,0801,2781,660
利息費用
22,05120,48619,43116,42215,08213,72314,02415,05714,99514,537
稅前純益
-31,333
-12,725
-40,455
-21,318
-29,524
-61,925
61,022
-56,344
-41,250
-49,935
所得稅
----------
稅後純益
-31,333
-12,725
-40,455
-21,318
-29,524
-61,925
61,022
-56,344
-41,250
-49,935
基本每股稅後盈餘(元)
-0.16-0.02-0.21-0.11-0.15-0.330.36-0.50-0.37-0.46
稀釋每股稅後盈餘(元)
-0.16-0.06-0.21-0.11-0.16-0.350.34-0.50-0.34-0.40
基本平均股數(千股)
200736.00197546.00196127.00195566.00194930.00188793.00169258.00112403.00111869.00109243.00
稀釋平均股數(千股)
200736.00197546.00196127.00195566.00194930.00188793.00189641.00112403.00111869.00109243.00
還原基本每股稅後盈餘(元)
-0.16-0.02-0.21-0.11-0.15-0.330.36-0.50-0.37-0.46
還原稀釋每股稅後盈餘(元)
-0.16-0.06-0.21-0.11-0.16-0.350.34-0.50-0.34-0.40
還原基本平均股數(千股)
200,736197,546196,127195,566194,930188,793169,258112,403111,869109,243
還原稀釋平均股數(千股)
200,736197,546196,127195,566194,930188,793189,641112,403111,869109,243
EBITDA(千元)
-8,4098,608-20,299-4,697-13,969-47,75075,483-40,850-25,802-34,998

大家都在看

HOT